Robert J Gould - Director, Fulcrum Therapeutics, Inc

As of April 11, 2022


Robert J Gould Net Worth

  • Net worth is estimated to be at least $22.53M
  • Owns at least 506,630 units of Fulcrum Therapeutics, Inc stock
  • Sold an estimated value of $3.22M in the last 3 years at Fulcrum Therapeutics, Inc

Robert J Gould Compensation at Fulcrum Therapeutics, Inc in 2020

  • Earned a $650,000 salary
  • Received a total compensation of $8,458,342

Robert J Gould Trading

  • Largest purchase of shares was 94,251 units , worth over $738.93K on April 5, 2022
  • Largest sale of shares was 94,251 units , worth over $2.28M on April 5, 2022
  • In total has made about 16 transactions over 3 years
  • Usually trades in June, with the busiest year in 2020
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Robert J Gould Mailing Address

  • Mailing address is C/o Epizyme, Inc. 400 Technology Square, 4th Floor Cambridge MA 02139 MA

Fulcrum Therapeutics, Inc Insider Trading

  • The most recent transaction was 5,631 units sold on April 11, 2022 by Robert J Gould worth over $135.23K
  • In the last 3 years, insiders at Fulcrum Therapeutics, Inc sold an estimated value of $6.27M and bought an estimated value of $11.52M
  • The most active traders are Robert J Gould, Director,  Diego Cadavid, SVP Clinical Development,  and Owen B Wallace, Chief Scientific Officer
  • Insider trading is most common in June, with the busiest year in 2020

Fulcrum Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1